Marketing status and perceived efficacy of drugs for supporting abstinence and reducing alcohol intake in alcohol use disorders: a survey among European federation of addiction societies in Europe

Background: Acamprosate, disulfiram (DIS), naltrexone and nalmefene can be used in treating alcohol use disorders. The drugs are, however, underutilized. Methods: In this survey of marketing status and perceived efficacy, member societies of the European federation for addiction societies were asked...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bramness, Jørgen Gustav (VerfasserIn) , Mann, Karl (VerfasserIn) , Wurst, Friedrich Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 21, 2016
In: European addiction research
Year: 2016, Jahrgang: 22, Heft: 6, Pages: 318-321
ISSN:1421-9891
DOI:10.1159/000447965
Online-Zugang:Verlag, Volltext: https://doi.org/10.1159/000447965
Verlag, Volltext: https://www.karger.com/Article/FullText/447965
Volltext
Verfasserangaben:Jørgen G. Bramness, Karl Mann, Friedrich M. Wurst

MARC

LEADER 00000caa a2200000 c 4500
001 1668364115
003 DE-627
005 20230427152719.0
007 cr uuu---uuuuu
008 190702s2016 xx |||||o 00| ||eng c
024 7 |a 10.1159/000447965  |2 doi 
035 |a (DE-627)1668364115 
035 |a (DE-599)KXP1668364115 
035 |a (OCoLC)1341231903 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bramness, Jørgen Gustav  |e VerfasserIn  |0 (DE-588)1054946663  |0 (DE-627)792434838  |0 (DE-576)411027441  |4 aut 
245 1 0 |a Marketing status and perceived efficacy of drugs for supporting abstinence and reducing alcohol intake in alcohol use disorders  |b a survey among European federation of addiction societies in Europe  |c Jørgen G. Bramness, Karl Mann, Friedrich M. Wurst 
264 1 |c July 21, 2016 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.07.2019 
520 |a Background: Acamprosate, disulfiram (DIS), naltrexone and nalmefene can be used in treating alcohol use disorders. The drugs are, however, underutilized. Methods: In this survey of marketing status and perceived efficacy, member societies of the European federation for addiction societies were asked to report on the status of these drugs in their country. Results were obtained from 20 European countries showing that the drugs were registered in most countries. Results and Conclusion: The drugs were mentioned in guidelines in approximately half and were partially or fully reimbursed in half to two-thirds countries. DIS was perceived as the most efficacious drug. These results are discussed. 
700 1 |a Mann, Karl  |d 1948-  |e VerfasserIn  |0 (DE-588)120426455  |0 (DE-627)080667872  |0 (DE-576)187088012  |4 aut 
700 1 |a Wurst, Friedrich Martin  |e VerfasserIn  |0 (DE-588)1027361439  |0 (DE-627)729003868  |0 (DE-576)373015127  |4 aut 
773 0 8 |i Enthalten in  |t European addiction research  |d Basel : Karger, 1995  |g 22(2016), 6, Seite 318-321  |h Online-Ressource  |w (DE-627)300191383  |w (DE-600)1482231-3  |w (DE-576)112438172  |x 1421-9891  |7 nnas  |a Marketing status and perceived efficacy of drugs for supporting abstinence and reducing alcohol intake in alcohol use disorders a survey among European federation of addiction societies in Europe 
773 1 8 |g volume:22  |g year:2016  |g number:6  |g pages:318-321  |g extent:4  |a Marketing status and perceived efficacy of drugs for supporting abstinence and reducing alcohol intake in alcohol use disorders a survey among European federation of addiction societies in Europe 
856 4 0 |u https://doi.org/10.1159/000447965  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.karger.com/Article/FullText/447965  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190702 
993 |a Article 
994 |a 2016 
998 |g 120426455  |a Mann, Karl  |m 120426455:Mann, Karl  |d 60000  |e 60000PM120426455  |k 0/60000/  |p 2 
999 |a KXP-PPN1668364115  |e 3490606728 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 02.07.2019"],"recId":"1668364115","name":{"displayForm":["Jørgen G. Bramness, Karl Mann, Friedrich M. Wurst"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"July 21, 2016"}],"language":["eng"],"person":[{"display":"Bramness, Jørgen Gustav","role":"aut","family":"Bramness","given":"Jørgen Gustav"},{"given":"Karl","family":"Mann","role":"aut","display":"Mann, Karl"},{"given":"Friedrich Martin","family":"Wurst","role":"aut","display":"Wurst, Friedrich Martin"}],"title":[{"title":"Marketing status and perceived efficacy of drugs for supporting abstinence and reducing alcohol intake in alcohol use disorders","subtitle":"a survey among European federation of addiction societies in Europe","title_sort":"Marketing status and perceived efficacy of drugs for supporting abstinence and reducing alcohol intake in alcohol use disorders"}],"relHost":[{"title":[{"title_sort":"European addiction research","title":"European addiction research"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"note":["Gesehen am 07.06.2019"],"disp":"Marketing status and perceived efficacy of drugs for supporting abstinence and reducing alcohol intake in alcohol use disorders a survey among European federation of addiction societies in EuropeEuropean addiction research","pubHistory":["1.1995 -"],"part":{"year":"2016","extent":"4","volume":"22","text":"22(2016), 6, Seite 318-321","pages":"318-321","issue":"6"},"id":{"zdb":["1482231-3"],"issn":["1421-9891"],"eki":["300191383"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"1995-","publisher":"Karger","publisherPlace":"Basel","dateIssuedKey":"1995"}],"recId":"300191383","titleAlt":[{"title":"The interdisciplinary journal for research, treatment, prevention and health policy"}]}],"physDesc":[{"extent":"4 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1668364115"],"doi":["10.1159/000447965"]}} 
SRT |a BRAMNESSJOMARKETINGS2120